ES437013A1 - Benzylpyrimidine derivatives - Google Patents

Benzylpyrimidine derivatives

Info

Publication number
ES437013A1
ES437013A1 ES437013A ES437013A ES437013A1 ES 437013 A1 ES437013 A1 ES 437013A1 ES 437013 A ES437013 A ES 437013A ES 437013 A ES437013 A ES 437013A ES 437013 A1 ES437013 A1 ES 437013A1
Authority
ES
Spain
Prior art keywords
group
formula
3alkenyl
3alkyl
see formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES437013A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES437013A1 publication Critical patent/ES437013A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Abstract

A procedure for the preparation of benzylpyrimidine derivatives of the general formula **(See formula)** in which R1 and R2 represent each one, independently, **(See formula)** a group of C1-3alkyl, C1-3alkoxy, C2-3alkenyl or C2-3alkenyloxy, Z represents an amino, pyrrolo, pyrrelidino, piperidino, -NHR4, -N (R4) 2, - group NHR5, -N (R4) (R5), -NR4COOR4, -NHCOOR4, -NHOONHR3, -NHCSNHR3, R4 represents a C1-3 alkyl or C2-3 alkenyl group, R5 represents an acyl group, R3 represents a hydrogen atom or a group of C1-3alkyl or C2-3alkenyl, and their salts, the process of which involves reducing the substituent indicated by X1 in a compound of the general formula. **(See formula)** where X1 represents a chlorine or bromine atom or a hydroxy group, Z1 is nitro or a group Z and R1, R2 and Z have the meaning indicated above in this claim, and converting, if desired, a compound of formula I obtained into a salt. (Machine-translation by Google Translate, not legally binding)
ES437013A 1973-09-12 1975-04-25 Benzylpyrimidine derivatives Expired ES437013A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (en) 1973-09-12 1973-09-12

Publications (1)

Publication Number Publication Date
ES437013A1 true ES437013A1 (en) 1977-04-01

Family

ID=4388903

Family Applications (7)

Application Number Title Priority Date Filing Date
ES429949A Expired ES429949A1 (en) 1973-09-12 1974-09-11 Benzylpyrimidine derivatives
ES437008A Expired ES437008A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437013A Expired ES437013A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437009A Expired ES437009A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437012A Expired ES437012A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437007A Expired ES437007A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437011A Expired ES437011A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES429949A Expired ES429949A1 (en) 1973-09-12 1974-09-11 Benzylpyrimidine derivatives
ES437008A Expired ES437008A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES437009A Expired ES437009A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437012A Expired ES437012A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437007A Expired ES437007A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437011A Expired ES437011A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives

Country Status (28)

Country Link
JP (1) JPS6042238B2 (en)
AR (2) AR207764A1 (en)
AT (1) AT338797B (en)
BE (1) BE819773A (en)
BR (1) BR7407614D0 (en)
CA (1) CA1037476A (en)
CH (1) CH591456A5 (en)
CU (1) CU34115A (en)
DD (2) DD122785A5 (en)
DE (1) DE2443682C2 (en)
DK (1) DK135683B (en)
ES (7) ES429949A1 (en)
FI (1) FI58638C (en)
FR (1) FR2242984B1 (en)
GB (3) GB1484481A (en)
HK (1) HK181A (en)
HU (1) HU170427B (en)
IE (1) IE40523B1 (en)
IL (1) IL45510A (en)
LU (1) LU70878A1 (en)
NL (1) NL155827B (en)
NO (1) NO140858C (en)
PH (1) PH10643A (en)
PL (2) PL97757B1 (en)
SE (1) SE419443B (en)
SU (3) SU577987A3 (en)
YU (3) YU217874A (en)
ZA (1) ZA745317B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
JPS5481278A (en) * 1977-10-18 1979-06-28 Wellcome Found Manufacture of triiseccaminomethane
CH639273A5 (en) 1978-09-12 1983-11-15 Hoffmann La Roche DIURETIC MEANS.
CH658246A5 (en) * 1981-11-09 1986-10-31 Wellcome Found METHOD FOR PRODUCING SUBSTITUTED 2,4-DIAMINO-5-BENZYLPYRIMIDINES.
DE3250132C2 (en) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc 2,4-Di:amino-5-benzyl-pyrimidine derivs. prepn.
GB2180836A (en) * 1985-09-27 1987-04-08 William James Stephen Barker Sunscreen
JPH0431685Y2 (en) * 1987-06-01 1992-07-30
CA1300166C (en) * 1987-12-03 1992-05-05 Alfredo Guerrato Process for the preparation of a benzoic acid ester
US4900859A (en) * 1987-12-03 1990-02-13 Hoffman-La Roche Inc. Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1103931B (en) * 1957-02-21 1961-04-06 Wellcome Found Process for the preparation of 2,4-diamino-5-benzylpyrimidine derivatives
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
ZA745317B (en) 1975-11-26
PH10643A (en) 1977-07-22
YU37154B (en) 1984-08-31
DE2443682C2 (en) 1983-11-10
BR7407614D0 (en) 1975-07-08
DD116824A5 (en) 1975-12-12
ES429949A1 (en) 1976-10-01
CU21022L (en) 1981-09-09
CA1037476A (en) 1978-08-29
IL45510A (en) 1978-08-31
DE2443682A1 (en) 1975-03-20
ES437008A1 (en) 1977-04-01
NL7411685A (en) 1975-03-14
DK135683C (en) 1977-11-14
FR2242984A1 (en) 1975-04-04
DK135683B (en) 1977-06-06
NO743271L (en) 1975-04-07
LU70878A1 (en) 1976-08-19
FI256174A (en) 1975-03-13
AR211387Q (en) 1977-12-15
FI58638B (en) 1980-11-28
GB1484482A (en) 1977-09-01
SE419443B (en) 1981-08-03
PL97757B1 (en) 1978-03-30
CU34115A (en) 1983-10-04
GB1484481A (en) 1977-09-01
DK468374A (en) 1975-05-12
GB1484483A (en) 1977-09-01
SE7411382L (en) 1975-03-13
YU301680A (en) 1983-04-27
HK181A (en) 1981-01-16
AU7263174A (en) 1976-02-26
JPS6042238B2 (en) 1985-09-20
SU577987A3 (en) 1977-10-25
HU170427B (en) 1977-06-28
YU217874A (en) 1982-06-18
CH591456A5 (en) 1977-09-15
ES437007A1 (en) 1977-04-01
SU571189A3 (en) 1977-08-30
AR207764A1 (en) 1976-10-29
FI58638C (en) 1981-03-10
BE819773A (en) 1975-03-11
JPS5053385A (en) 1975-05-12
ES437009A1 (en) 1977-04-01
NO140858B (en) 1979-08-20
ES437011A1 (en) 1977-04-01
YU37153B (en) 1984-08-31
ES437012A1 (en) 1977-04-01
IE40523B1 (en) 1979-06-20
NO140858C (en) 1979-11-28
IL45510A0 (en) 1974-11-29
YU301580A (en) 1983-04-27
FR2242984B1 (en) 1977-11-04
AT338797B (en) 1977-09-12
SU609465A3 (en) 1978-05-30
NL155827B (en) 1978-02-15
ATA735174A (en) 1977-01-15
IE40523L (en) 1975-03-12
PL99159B1 (en) 1978-06-30
DD122785A5 (en) 1976-11-05

Similar Documents

Publication Publication Date Title
ES462061A1 (en) Tetrahydroisoquinoline basic ethers and pharmaceutical compositions and methods employing them
ES437013A1 (en) Benzylpyrimidine derivatives
ES398289A1 (en) Animal feed containing 7-isopropoxy-isoflavone
ES413639A1 (en) Dopamine derivatives
ES387016A1 (en) Isoquinoline derivatives
ES330368A1 (en) Procedure for preparing N-alcohilamino-alcohilic derivatives of espirotetralinosuccinimidas and their salts. (Machine-translation by Google Translate, not legally binding)
ES2012648A6 (en) 1,4-benzoxazine and 1,4-benzothiazine derivatives and process for their preparation.
ES392093A1 (en) 2-amino-5-chloro-thiazole derivatives
GB1382965A (en) Morpholine derivatives
ES440030A1 (en) 2-aminoindane derivatives
ES405479A1 (en) Benzodiazepin-2-ones
ATE30152T1 (en) 1-METHYL-5-NITRO-IMIDAZOLINE DERIVATIVES AND THERAPEUTIC COMPOSITIONS CONTAINING THEM.
ES419386A1 (en) Indenopyrrole derivatives
ES333664A1 (en) A procedure for the preparation of antibacterial agents. (Machine-translation by Google Translate, not legally binding)
ES465136A1 (en) Acyl derivatives of hellebrigenin
ES374901A1 (en) Benzomorphan derivatives and their salts
ES442023A1 (en) Phenylpropanolamines
ES426948A1 (en) Procedure for the preparation of new 1,4-benzodiazepinas. (Machine-translation by Google Translate, not legally binding)
ES401342A1 (en) Pyridine derivatives
ES382147A1 (en) A procedure for preparing N-substituted morpholine compounds. (Machine-translation by Google Translate, not legally binding)
ES402181A1 (en) Procedure for the obtaining of derivatives of 5-nitrofurilo. (Machine-translation by Google Translate, not legally binding)
ES428624A1 (en) Procedure for the preparation of pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding)
ES398868A1 (en) Process for the preparation of derivatives of 1,2-diphenyl-3,5- dioxo-4-n-butylpyrazolidine
ES393340A1 (en) Amines and a process for the manufacture thereof
ES403885A1 (en) A procedure for preparing derivatives substituted in n 'of N- (trimetoxy-3,4,5) cinamoil-piperazine. (Machine-translation by Google Translate, not legally binding)